Mode
Text Size
Log in / Sign up

Oncology

1416 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Node-RADS demonstrates high diagnostic accuracy for lymph node metastasis in rectal cancer patients
Oncology Meta-analysis
Node-RADS demonstrates high diagnostic accuracy for lymph node metastasis in rectal cancer patients Node-RADS Shows Promise for Detecting Rectal Cancer Lymph Node Spread
This systematic review and meta-analysis of 994 patients evaluated the diagnostic accuracy of Node-RADS for identifying lymph node metastasi…
A new imaging system called Node-RADS may help doctors better identify if rectal cancer has spread to nearby lymph nodes before surgery.
Machine learning models demonstrate high diagnostic accuracy for predicting postoperative outcomes in vestibular schwannoma
Oncology Meta-analysis
Machine learning models demonstrate high diagnostic accuracy for predicting postoperative outcomes in vestibular schwannoma Machine learning helps predict surgical risks for vestibular schwannoma
This meta-analysis of 10 retrospective cohort studies evaluates machine learning models for predicting facial nerve dysfunction and hearing …
New machine learning models show promise in predicting whether patients will keep their hearing or face function after surgery.
Metallic ureteric stents show a trend toward lower failure rates than polymeric stents in malignant obstruction
Oncology Meta-analysis
Metallic ureteric stents show a trend toward lower failure rates than polymeric stents in malignant obstruction Metallic stents may lower failure rates in certain kidney conditions
This meta-analysis of 511 patients with chronic malignant ureteric obstruction compared metallic and polymeric stents. The analysis found a …
New data suggests metallic stents might last longer than plastic ones for patients with blocked ureters caused by cancer.
Stereotactic radiotherapy combined with ranibizumab for neovascular age-related macular degeneration shows potential cost benefits
Oncology RCT
Stereotactic radiotherapy combined with ranibizumab for neovascular age-related macular degeneration shows potential cost benefits Radiotherapy Shows Potential Cost Savings for Macular Degeneration Patients
Researchers evaluated the impact of stereotactic radiotherapy alongside ranibizumab for patients with neovascular age-related macular degene…
A trial suggests that adding stereotactic radiotherapy to standard care may lower healthcare costs and help track quality of life in macular…
Brucea javanica oil emulsion reduces chemoradiotherapy adverse effects and improves immune markers in cervical cancer
Oncology Meta-analysis
Brucea javanica oil emulsion reduces chemoradiotherapy adverse effects and improves immune markers in cervical cancer Brucea javanica Oil May Reduce Side Effects of Cervical Cancer Treatment
This meta-analysis of 372 patients indicates that Brucea javanica oil emulsion (BJOE) significantly reduces treatment-related side effects l…
A review suggests that Brucea javanica oil may reduce nausea and other side effects for patients undergoing cervical cancer treatment.
Multimodal machine learning integrates diverse data to support clinical decision making in glioblastoma management
Oncology Sys. Review
Multimodal machine learning integrates diverse data to support clinical decision making in glioblastoma management Machine Learning May Improve Diagnosis for Glioblastoma Patients
This mini review explores the role of multimodal machine learning (MML) in integrating longitudinal MRI, histopathology, and molecular profi…
New machine learning models can combine multiple types of medical data to help doctors better understand glioblastoma and predict patient ou…
Multimodal AI and machine learning integration improves risk prediction and prognostic modeling in cancer management
Oncology Sys. Review
Multimodal AI and machine learning integration improves risk prediction and prognostic modeling in cancer management Artificial intelligence helps doctors predict cancer risks and treatment paths
This narrative review explores the role of multimodal artificial intelligence and machine learning in oncology. The authors synthesize how i…
New computer models combine tissue samples and genetic data to help doctors better predict cancer outcomes and plan personalized treatments.
Isolated gastric Langerhans cell histiocytosis diagnosed by endoscopy and immunohistochemistry in an adult case report
Oncology Sys. Review
Isolated gastric Langerhans cell histiocytosis diagnosed by endoscopy and immunohistochemistry in an adult case report Rare Stomach Lesion Identified as Langerhans Cell Histiocytosis
This case report and literature review describes an adult with isolated gastric Langerhans cell histiocytosis presenting as an erosive lesio…
A rare stomach lesion turned out to be Langerhans cell histiocytosis, a condition usually seen in children. Learn what this case means for d…
Single-port robot-assisted partial nephrectomy reduces estimated blood loss by 16.62 mL compared to multi-port
Oncology Meta-analysis
Single-port robot-assisted partial nephrectomy reduces estimated blood loss by 16.62 mL compared to multi-port Single Port Surgery Shows Less Blood Loss for Renal Tumors
This meta-analysis of 442 patients with low-complexity renal tumors found that single-port robot-assisted partial nephrectomy (SP-RAPN) resu…
A single-port robotic approach may reduce blood loss during certain kidney tumor surgeries compared to multi-port methods.
FDA Approves Zelboraf (vemurafenib) for BRAF V600E Melanoma and Erdheim-Chester Disease
Oncology FDA Approval
FDA Approves Zelboraf (vemurafenib) for BRAF V600E Melanoma and Erdheim-Chester Disease FDA approves new drug Zelboraf for advanced melanoma with BRAF mutation
The FDA approved Zelboraf (vemurafenib) for unresectable or metastatic melanoma with BRAF V600E mutation and for Erdheim-Chester Disease wit…
The FDA has approved Zelboraf (vemurafenib) for adults with advanced melanoma that has a specific BRAF V600E mutation. It is also approved f…
FDA Approves Cotellic (cobimetinib) for BRAF V600 Melanoma and Histiocytic Neoplasms
Oncology FDA Approval
FDA Approves Cotellic (cobimetinib) for BRAF V600 Melanoma and Histiocytic Neoplasms FDA approves new drug Cotellic for certain skin and blood cancers
The FDA approved Cotellic (cobimetinib) for two indications: in combination with vemurafenib for unresectable or metastatic melanoma with BR…
The FDA has approved Cotellic (cobimetinib) for adults with advanced melanoma that has a specific gene change, and for a rare group of blood…
Erector spinae plane block provides comparable analgesic efficacy to paravertebral plane block in breast cancer surgery
Oncology Meta-analysis
Erector spinae plane block provides comparable analgesic efficacy to paravertebral plane block in breast cancer surgery Comparing Two Different Nerve Blocks for Pain Relief During Breast Cancer Surgery
This meta-analysis of 1527 patients undergoing breast cancer surgeries compared erector spinae plane block (ESPB) to paravertebral plane blo…
Doctors compared two types of nerve blocks to see which method provided better pain relief and faster surgery times for breast cancer patien…